Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysisWai-Nga Chan, Chen‐Li Cheng|Frontiers in Oncology|2022Cited by 2